Unknown

Dataset Information

BNT162b2 vaccination enhances interferon-JAK-STAT-regulated antiviral programs in COVID-19 patients infected with the SARS-CoV-2 Beta variant.


ABSTRACT:

Background

SARS-CoV-2 infection activates interferon-controlled signaling pathways and elicits a wide spectrum of immune responses and clinical manifestations in human patients.

Methods

Here, we investigate the impact of prior vaccination on the innate immune response of hospitalized COVID-19 patients infected with the SARS-CoV-2 Beta variant through RNA sequencing of peripheral blood immune cells. Four patients had received the first dose of BNT162b2 about 11 days prior to the onset of COVID-19 symptoms and five patients were unvaccinated. Patients had received dexamethasone treatment. Immune transcriptomes were obtained at days 7-13, 20-32 and 42-60 after first symptomology.

Results

RNA-seq reveals an enhanced JAK-STAT-mediated immune transcriptome response at day 1

SUBMITTER: Knabl L 

PROVIDER: S-EPMC9029844 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature